A detailed history of Focused Wealth Management, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Focused Wealth Management, Inc holds 3,000 shares of ABBV stock, worth $511,050. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,000
Previous 6,216 51.74%
Holding current value
$511,050
Previous $1.07 Million 44.47%
% of portfolio
0.08%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$163.84 - $199.33 $4,096 - $4,983
25 Added 0.4%
6,241 $1.23 Million
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $13,776 - $16,087
-89 Reduced 1.41%
6,216 $1.07 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $33,722 - $38,423
211 Added 3.46%
6,305 $1.15 Million
Q4 2023

Jan 10, 2024

BUY
$137.6 - $154.97 $22,979 - $25,879
167 Added 2.82%
6,094 $944,000
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $11,221 - $12,990
84 Added 1.44%
5,927 $883,000
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $27,562 - $34,299
-208 Reduced 3.44%
5,843 $787,000
Q1 2023

Apr 13, 2023

BUY
$144.61 - $166.54 $29,789 - $34,307
206 Added 3.52%
6,051 $964,000
Q4 2022

Jan 13, 2023

BUY
$138.31 - $165.87 $342,870 - $411,191
2,479 Added 73.65%
5,845 $0
Q3 2022

Oct 20, 2022

BUY
$134.21 - $153.93 $40,665 - $46,640
303 Added 9.89%
3,366 $452,000
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $25,734 - $32,717
-187 Reduced 5.75%
3,063 $469,000
Q1 2022

Apr 29, 2022

BUY
$131.98 - $163.75 $2,243 - $2,783
17 Added 0.53%
3,250 $527,000
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $2,256 - $2,854
21 Added 0.65%
3,233 $438,000
Q3 2021

Oct 12, 2021

BUY
$106.4 - $120.78 $22,450 - $25,484
211 Added 7.03%
3,212 $346,000
Q2 2021

Jul 15, 2021

BUY
$105.21 - $117.21 $1,893 - $2,109
18 Added 0.6%
3,001 $338,000
Q1 2021

May 03, 2021

BUY
$102.3 - $112.62 $22,301 - $24,551
218 Added 7.88%
2,983 $323,000
Q4 2020

Feb 03, 2021

SELL
$80.49 - $108.67 $4,185 - $5,650
-52 Reduced 1.85%
2,765 $296,000
Q3 2020

Oct 19, 2020

SELL
$85.91 - $100.83 $108,160 - $126,944
-1,259 Reduced 30.89%
2,817 $247,000
Q2 2020

Jul 24, 2020

BUY
$73.37 - $98.18 $182,471 - $244,173
2,487 Added 156.51%
4,076 $400,000
Q1 2020

May 06, 2020

BUY
$64.5 - $97.79 $3,870 - $5,867
60 Added 3.92%
1,589 $121,000
Q4 2019

Jan 21, 2020

SELL
$72.13 - $90.25 $3,029 - $3,790
-42 Reduced 2.67%
1,529 $135,000
Q3 2019

Nov 06, 2019

BUY
$62.98 - $75.72 $566 - $681
9 Added 0.58%
1,571 $119,000
Q2 2019

Jul 19, 2019

SELL
$65.7 - $83.98 $8,081 - $10,329
-123 Reduced 7.3%
1,562 $114,000
Q1 2019

May 03, 2019

BUY
$77.14 - $90.79 $462 - $544
6 Added 0.36%
1,685 $136,000
Q4 2018

Jan 30, 2019

BUY
$77.85 - $96.01 $19,929 - $24,578
256 Added 17.99%
1,679 $155,000
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $88 - $98
1 Added 0.07%
1,423 $135,000
Q2 2018

Aug 15, 2018

BUY
$89.78 - $106.23 $448 - $531
5 Added 0.35%
1,422 $132,000
Q1 2018

May 07, 2018

BUY
$92.01 - $123.21 $460 - $616
5 Added 0.35%
1,417 $134,000
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $72,095 - $79,059
-805 Reduced 36.31%
1,412 $137,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $56,927 - $72,714
815 Added 58.13%
2,217 $197,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,402
1,402 $102,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Focused Wealth Management, Inc Portfolio

Follow Focused Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.